Free Clinical Webinars

    Which state do you practice in?*

    Florida County*

    Low Dose Naltrexone with Belmar LDN Expert

    Low-dose naltrexone works by boosting your natural endorphins. Endorphins are hormones produced by your body to relieve stress and pain. They trigger positive feelings and are thought to be the cause of ‘runner’s high.’ Endorphins also help regulate the immune system, calming it down in autoimmune disorders, and revving it up when needed.

    The webinar is presented by Belmar Pharma Solutions’ LDN Expert Sam Lebsock, PharmD and Medical Director Angela DeRosa DO, MBA, CPE.

    Implement Pellets in 30 Days

    In this presentation, Dr. Angela DeRosa offers her 25 years of expertise in hormone pellet therapy and will guide you through how to strategically and successfully add hormone pellet therapy in your medical practice. Additionally, she will address the common myths and misperceptions of hormone replacement therapy and hormone pellet therapy.

    Learn the advantages of using pellets for Bio-Identical Hormone Replacement Therapy – BHRT while implementing them into your practice with your current patient base. Other important considerations when starting Hormone Therapy include choosing the right compounding pharmacy partner and receiving proper pellet therapy training.

    All of this combined, and much more, can help you Implement Hormone Pellet Therapy in 30 Days.

    Ready to Watch?

    Medical Weight Loss: No HCG, Now What?

    As compounded HCG is no longer available for your patients, Dr. Angela DeRosa will offer alternatives to help you successfully develop and implement a refreshed medical weight loss program. Her extensive experience in this area will bring new light to your current programs without HCG, and help you establish new services for your patients. Dr. DeRosa will present medication alternatives available through APS Belmar Pharmacy and more.

    Inflammatory Response and Covid-19

    Are COVID-19 vaccines and/or infections contributing to a clinically important inflammatory response in patients and specifically in those undergoing hormonal therapies?

    Since the onset of the pandemic, I have observed an increasing number of discussions and concerns amongst colleagues and outside experts wondering if there is a connection to the COVID-19 vaccine and/or COVID-19 infection, the inflammatory response, its possible role in changes to patients’ responses to hormone therapies and specifically more extrusions/infections with pellet therapies.

    Given these discussions, many folks expressed a desire to have open, honest, and critical discussions about this as well as an opportunity to hear others’ clinical experiences and possible approaches to this potential connection. – Angela DeRosa

    Disclaimer: Angela DeRosa, DO, MBA, CPE is the founder of the Hormonal Health Institute and serves as a paid consultant to Belmar Pharma Solutions. Dr. DeRosa is not an employee of Belmar Pharma Solutions* and nothing herein should be construed as the promotion of Belmar Pharma Solutions compounded products over other hormone replacement therapies. Patients interested in pellet therapy or compounded medications are encouraged to speak to a medical professional about their medical options and before seeking treatment. All information provided herein is based on Dr. DeRosa’s own clinical experience in her capacity as a board-certified internist. Nothing herein should be construed as making a claim about the safety or effectiveness of compounded products, which includes compounded hormone pellet therapy.